glp-1 biosimilar Drugs Market Size to Hit USD 132.79 Bn by 2035 Biocon's Biosimilar Push Faces Fierce

Sheets C, Peden M, Guy J

(1) Supporting tests help establish the link to liver disease

2020;9:F1000 Faculty Rev53

Eligibility under TA875 requires the presence of at least one weight-related comorbidity and a BMI of 35 kg/m or above

Microbiological part For the testing of antimicrobial activity, four bacterial strains were used: two reference strains Staphylococcus aureus (ATCC 29213) and Pseudomonas aeruginosa (ATCC 27853) supplied by the Czech Collection of Microorganisms, Masaryk University Brno, and two clinical isolates Staphylococcus pseudintermedius and Pseudomonas aeruginosa supplied by the Veterinary University in Brno